InfuSystem Holdings (INFU) Cash from Investing Activities (2010 - 2026)

InfuSystem Holdings (INFU) reported Cash from Investing Activities of -$1.3 million for Q1 2026, up 52.65% on a YoY basis from -$825421.0 in Q1 2025, and up 42.52% quarter-over-quarter from -$2.2 million in Q4 2025.

InfuSystem Holdings (INFU) Cash from Investing Activities (2010 - 2026) Analysis & Trends

InfuSystem Holdings has reported Cash from Investing Activities for 17 years, with the latest figure at -$1.3 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Investing Activities rose 52.65% year-over-year to -$1.3 million; the trailing twelve-month figure through Mar 2026 stood at -$5.4 million (up 65.19% YoY), and the FY2025 full-year result was -$6.8 million, up 48.71% from the prior year.
  • Cash from Investing Activities for Q1 2026 stood at -$1.3 million, up from -$2.2 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was -$252000.0 in Q3 2025, with the low at -$6.7 million in Q2 2024.
  • Historically, Cash from Investing Activities has averaged -$2.3 million across 5 years, with a median of -$2.3 million in 2023.
  • Annual changes were most pronounced in 2023 — Cash from Investing Activities soared 91.43% — and 2024, when it slumped 852.0%.
  • InfuSystem Holdings' Cash from Investing Activities stood at -$3.1 million in 2022, then surged by 65.79% to -$1.0 million in 2023, then tumbled by 213.12% to -$3.3 million in 2024, then surged by 32.95% to -$2.2 million in 2025, then jumped by 42.52% to -$1.3 million in 2026.
  • The last three Cash from Investing Activities figures came in at -$1.3 million (Q1 2026), -$2.2 million (Q4 2025), and -$252000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -20.32 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -185.00 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -816.00 Mn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -591.00 Mn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -92.80 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -475.32 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -298.50 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -2.50 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -217.20 Mn
10 InfuSystem Holdings 189.78 Mn 187.68 Mn 19.68 Mn -1.26 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.26 Mn
Mar 31, 2026 -1.26 Mn
Dec 31, 2025 -2.19 Mn
Dec 31, 2025 -2.19 Mn
Sep 30, 2025 -252,000.00
Sep 30, 2025 -252,000.00
Jun 30, 2025 -1.69 Mn
Jun 30, 2025 -1.69 Mn
Mar 31, 2025 -2.66 Mn
Mar 31, 2025 -2.66 Mn
Dec 31, 2024 -3.27 Mn
Dec 31, 2024 -3.27 Mn
Sep 30, 2024 -2.86 Mn
Sep 30, 2024 -2.86 Mn
Jun 30, 2024 -6.70 Mn
Jun 30, 2024 -6.70 Mn
Mar 31, 2024 -418,000.00
Mar 31, 2024 -418,000.00
Dec 31, 2023 -1.04 Mn
Dec 31, 2023 -1.04 Mn